help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beckers, A.
Right arrow Articles by Stevenaert, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beckers, A.
Right arrow Articles by Stevenaert, A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Adrenal Gland Cancer

Journal of Clinical Endocrinology & Metabolism, Vol 75, 564-570, Copyright © 1992 by Endocrine Society


ARTICLES

Aldosterone-secreting adrenal adenoma as part of multiple endocrine neoplasia type 1 (MEN1): loss of heterozygosity for polymorphic chromosome 11 deoxyribonucleic acid markers, including the MEN1 locus

A Beckers, R Abs, PJ Willems, B van der Auwera, K Kovacs, M Reznik and A Stevenaert
Department of Endocrinology, University of Liege, Belgium.

A 63-year-old female presented with the extremely rare occurrence of an aldosterone-secreting adrenocortical adenoma as part of the syndrome of multiple endocrine neoplasia type 1 (MEN1). Only two other MEN1 patients were reported in the literature with hyperaldosteronism. The patient's MEN1 syndrome consisted of the association of primary hyperparathyroidism due to parathyroid adenoma, a prolactinoma, and a toxic multinodular goiter. Elevated basal and meal-stimulated serum PP levels without demonstrable pancreatic tumor were also found. Genetic analysis of the aldosterone-secreting adenoma with DNA markers localized on chromosome 11 showed loss of heterozygosity in tumor DNA. Since the MEN1 syndrome is caused by loss of the tumor suppressor gene on chromosome 11 in the 11q13 region, it is probable that the same mechanism is associated with the formation of the adrenocortical adenoma.


This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
S Schaefer, M Shipotko, S Meyer, D Ivan, K J Klose, J Waldmann, P Langer, and P H Kann
Natural course of small adrenal lesions in multiple endocrine neoplasia type 1: an endoscopic ultrasound imaging study
Eur. J. Endocrinol., May 1, 2008; 158(5): 699 - 704.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. C. Figueiredo, L. R. Cavalli, M. A. D. Pianovski, E. Lalli, R. Sandrini, R. C. Ribeiro, G. Zambetti, L. DeLacerda, G. A. Rodrigues, and B. R. Haddad
Amplification of the Steroidogenic Factor 1 Gene in Childhood Adrenocortical Tumors
J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 615 - 619.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
C. Caliumi, G. De Toma, A. Bossini, R. Cianci, C. Bosman, M. Genuardi, S. Cerci, and C. Letizia
A rare combination consisting of aldosterone-producing adenoma and adrenal myelolipoma in a patient with heterozygosity for retinoblastoma (RB) gene
Journal of Renin-Angiotensin-Aldosterone System, March 1, 2004; 5(1): 45 - 48.
[Abstract] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. A. Koch, K. Pacak, and G. P. Chrousos
The Molecular Pathogenesis of Hereditary and Sporadic Adrenocortical and Adrenomedullary Tumors
J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5367 - 5384.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. L. Brandi, R. F. Gagel, A. Angeli, J. P. Bilezikian, P. Beck-Peccoz, C. Bordi, B. Conte-Devolx, A. Falchetti, R. G. Gheri, A. Libroia, et al.
CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2
J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5658 - 5671.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K.-M. Schulte, M. Mengel, M. Heinze, D. Simon, S. Scheuring, K. Köhrer, and H.-D. Röher
Complete Sequencing and Messenger Ribonucleic Acid Expression Analysis of the MEN I Gene in Adrenal Cancer
J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 441 - 448.
[Abstract] [Full Text]


Home page
ANN INTERN MEDHome page
S. R. Bornstein, C. A. Stratakis, and G. P. Chrousos
Adrenocortical Tumors: Recent Advances in Basic Concepts and Clinical Management
Ann Intern Med, May 4, 1999; 130(9): 759 - 771.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. C. Figueiredo, C. A. Stratakis, R. Sandrini, L. DeLacerda, M. A. D. Pianovsky, C. Giatzakis, H. M. Young, and B. R. Haddad
Comparative Genomic Hybridization Analysis of Adrenocortical Tumors of Childhood
J. Clin. Endocrinol. Metab., March 1, 1999; 84(3): 1116 - 1121.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Kjellman, L. Roshani, B. T. Teh, O.-P. Kallioniemi, A. Höög, S. Gray, L.-O. Farnebo, M. Holst, M. Bäckdahl, and C. Larsson
Genotyping of Adrenocortical Tumors: Very Frequent Deletions of the MEN1 Locus in 11q13 and of a 1-Centimorgan Region in 2p16
J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 730 - 735.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Heppner, M. Reincke, S. K. Agarwal, P. Mora, B. Allolio, A. L. Burns, A. M. Spiegel, and S. J. Marx
MEN1 Gene Analysis in Sporadic Adrenocortical Neoplasms
J. Clin. Endocrinol. Metab., January 1, 1999; 84(1): 216 - 219.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1992 by The Endocrine Society